ABAI, AAAAI, ACAAI, CIS Joint Statement on the Impact of the U.S. Supreme Court Dobbs v. Jackson Women’s Health Organization ruling and Emerging Legislation on Patients, Physicians and the Practice of Medicine
The American Board of Allergy and Immunology (ABAI), American Academy of Allergy, Asthma and Immunology (AAAAI), American College of Allergy, Asthma & Immunology (ACAAI), and Clinical Immunology Society (CIS) are committed to serving the public by certifying and providing state of the art continuing medical education services for allergists and clinical immunologists committed to lifelong learning and providing exceptional care for patients with allergic and immunologic diseases.
ABAI, AAAAI, ACAAI and CIS are concerned about intrusion on the physician-patient relationship and challenges to delivery of evidence-based care as a result of the recent United States Supreme Court Dobbs v. Jackson Women's Health Organization ruling.
We jointly agree that the result of this ruling could lead to subsequent state legislation that sets an undesirable precedent of judicial and legislative interference with patient access to high quality health care and the ability of physicians to provide evidence-based care with shared decision-making by patients.
We also recognize that patients undergoing care for reproductive health often require care by other medical subspecialties including allergy-immunology. These circumstances present a challenge for allergist-immunologists to provide the full scope of evidence-based care to our patients directly and indirectly affected by current and proposed legislation. Our specialty strives to eliminate barriers for our patients, and our commitment to allergy-immunology specialists and the communities we serve is unwavering.
We embrace the diversity of allergy-immunology specialists and the patients entrusted to our care. Accordingly, the ABAI, AAAAI, ACAAI, and CIS are concerned with any rule, law or regulation that impacts our ability to provide the best care to our patients who look to us for evidence-based treatment options for their allergic & immunologic conditions.
We will continue to monitor for further legislative challenges that impact the physician-patient relationship and allergist-immunologists’ ability to provide safe, effective and evidence-based care.